Abstract:
Dengvaxia, the first Dengue vaccine in the world, was launched in Thailand in early 2017 by Sanofi Pasteur Company. It is used to prevent Dengue infection in children and adults (age 9-45) living in endemic areas (Dengue Vaccine Initiative, 2016). The Philippines was the first country to launch the Dengue vaccine, while Thailand was the third to launch this innovative vaccine. Due to its relatively expensive price, there have been some challenges in promoting this vaccine to the target customers, which are patients in private hospitals. Therefore, this study in applied marketing which focuses on health, aims to analyze and recommend effective promotional strategies and payment solutions. Secondary research and in-depth interviews with healthcare practitioners and marketing managers of private hospitals were conducted. The results and recommendations from this research will be beneficial to both the manufacturing company and private hospitals, enabling them to create effective promotional strategies and find an optimal payment solution for patients, in order to increase the sales of dengue vaccines in private hospitals and to prevent the spread of the Dengue virus. The factors influencing the purchasing decision of vaccines in private hospitals include 1) Word of mouth 2) Efficacy of vaccine 3) Convenience and 4) Promotion. Based on these findings, the researcher was able to provide recommendations on the promotional campaigns and payment method for dengue vaccination in private hospitals
Thammasat University. Thammasat University Library